Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
Build It or Buy It: Novel Assays to Identify and Characterize Tuberculosis
“Expanding spoligotyping of multidrug-resistant tuberculosis to the Luminex xMAP® platform to increase reproducibility, flexibility and throughput
Approximately one third of the world’s population is infected with the tuberculosis (TB) bacteria, Mycobacterium tuberculosis Complex (MTBC), which is one of the deadliest infectious diseases world-wide. One of the greatest threats to global TB control is the growing prevalence of drug resistant strains…”
Continue Reading…
Experience an ARIES® System & SYNCT™ Software, enabling cassettes to be associated with orders from anywhere in the lab network.
Watch more videos >
Something went wrong with the twitter.
July 28
Luminex Corporation Reports Second Quarter 2016 Results
July 8
Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016
July 6
Luminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System
34th Annual Conference on Pediatric Infectious Diseases
July 31-August 5
Vail, CO
AACC Annual Meeting & Clinical Lab Expo
August 2-4
Philadelphia, PA
SWACM Annual Meeting
September 7-10
Ft. Worth, TX
IDWeek
October 26-30
New Orleans, LA
AMP Annual Meeting
November 10-12
Charlotte, NC
